Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Bone resorption
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 17 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Dec 2005 New trial record.